Medium- and Large-Vessel Vasculitis

被引:103
|
作者
Saadoun, David [1 ,2 ,3 ]
Vautier, Mathieu [1 ]
Cacoub, Patrice [2 ,3 ]
机构
[1] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Assistance Publ Hopitaux Paris AP HP,Ctr Natl Ref, Dept Internal Med & Clin Immunol,Ctr Natl Referen, Paris, France
[2] Inst Natl Sante & Rech Med INSERM, Unite Mixte Rech UMR S 959, Paris, France
[3] Rech Hosp Univ Sante RHU Interleukin, Therapy Autoimmune & Inflammatory Dis 2, Paris, France
关键词
giant cell arteritis; Kawasaki disease; polyarteritis nodosa; Takayasu; vasculitis;
D O I
10.1161/CIRCULATIONAHA.120.046657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic vasculitides are multisystem blood vessel disorders, which are defined by the size of the vessel predominantly affected, namely small, medium, or large vessels. The term "large vessel" relates to the aorta and its major branches; "medium vessel" refers to the main visceral arteries and veins and their initial branches. The most common causes of large-vessel vasculitis are giant cell arteritis and Takayasu arteritis, and those of medium-vessel arteritis are polyarteritis nodosa and Kawasaki disease. However, there is some overlap, and arteries of any size can potentially be involved in any of the 3 main categories of dominant vessel involvement. In addition to multisystem vasculitides, other forms of vasculitis have been defined, including single-organ vasculitis (eg, isolated aortitis). Prompt identification of vasculitides is important because they are associated with an increased risk of mortality. Left undiagnosed or mismanaged, these conditions may result in serious adverse outcomes that might otherwise have been avoided or minimized. The ethnic and regional differences in the incidence, prevalence, and clinical characteristics of patients with vasculitis should be recognized. Because the clinical presentation of vasculitis is highly variable, the cardiovascular clinician must have a high index of suspicion to establish a reliable and prompt diagnosis. This article reviews the pathophysiology, epidemiology, diagnostic strategies, and management of vasculitis.
引用
收藏
页码:267 / 282
页数:16
相关论文
共 50 条
  • [31] Current and emerging therapies in large-vessel vasculitis
    Kermani, Tanaz A.
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2018, 57 (09) : 1513 - 1524
  • [32] New Therapeutic Approaches to Large-Vessel Vasculitis
    Kaymakci, Mahmut S.
    Warrington, Kenneth J.
    Kermani, Tanaz A.
    ANNUAL REVIEW OF MEDICINE, 2024, 75 : 427 - 442
  • [33] New treatment strategies in large-vessel vasculitis
    Unizony, Sebastian
    Stone, John H.
    Stone, James R.
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (01) : 3 - 9
  • [34] The potentials and importance of imaging in large-vessel vasculitis
    Kolossvary Endre
    Balazs Gyorgy
    Dosa Edit
    Morayszki Monika
    Jarai Zoltan
    Farkas Katalin
    ORVOSI HETILAP, 2020, 161 (23) : 939 - 950
  • [35] Medium and large vessel vasculitis
    Clivati Brandt, Hebert Roberto
    Arnone, Marcelo
    Sakai Valente, Neusa Yuriko
    Sotto, Mirian Nacagami
    Criado, Paulo Ricardo
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2009, 84 (01) : 55 - 67
  • [36] PET/CT for Diagnosis and Management of Large-Vessel Vasculitis
    Pelletier-Galarneau, Matthieu
    Ruddy, Terrence D.
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (05)
  • [37] What is the best approach to diagnosing large-vessel vasculitis?
    Schmidt, WA
    Gromnica-Ihle, E
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (02): : 223 - 242
  • [38] Tocilizumab: a novel therapy for patients with large-vessel vasculitis
    Salvarani, Carlo
    Magnani, Luca
    Catanoso, Mariagrazia
    Pipitone, Nicolo
    Versari, Annibale
    Dardani, Lucia
    Pulsatelli, Lia
    Meliconi, Riccardo
    Boiardi, Luigi
    RHEUMATOLOGY, 2012, 51 (01) : 151 - 156
  • [39] Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome
    Yabe, Hiroki
    INTERNAL MEDICINE, 2018, 57 (19) : 2769 - 2771
  • [40] Longitudinal Patterns of Vascular Inflammation in Large-vessel Vasculitis
    Alessi, Hugh
    Quinn, Kaitlin
    Ahlman, Mark A.
    Luo, Yiming
    Novakovich, Elaine
    Grayson, Peter
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1045 - 1046